Low Particle Emission and Low Noise Tyres (LEON-T)

This study will investigate the biological mechanisms linking sleep disruption by noise and the development of disease. In a laboratory sleep study, the investigators will play synthesised automotive tyre sounds, investigating how acoustical characteristics of tyre noise impact on sleep macrostructure, cardiometabolic profile and cognitive performance (continuous traffic flow or a few individual, but higher level, traffic pass-bys). The investigators will also measure objective sleep quality and quantity, cognitive performance across multiple domains, self-reported sleep and wellbeing outcomes, and blood samples. Blood samples will be analysed to identify metabolic changes in different nights. Identifying biomarkers that are impacted by sleep fragmentation will establish the currently unclear pathways by which chronic noise exposure at night can lead to the development of diseases in the long term, especially cardiometabolic disorders.

Study Overview

• Status: Completed
• Conditions: Cognitive Change; Sleep Disturbance; Metabolic Disturbance; Noise Exposure; Sleep Hygiene
• Intervention / Treatment: Radiation: Tyre noise - continuous flow; Radiation: High noise level; Radiation: Moderate noise level; Radiation: Tyre noise - discrete events; Radiation: Composite tyres; Radiation: Low noise level; Radiation: Air-filled tyres

Detailed Description

The experimental sleep study has the overarching goal of deepening our understanding of sleep disruption by automotive tyre noise and changes in cardiometabolic and cognitive function. To this end, the study will address the following independent aims:

Aim 1: Determine the biological and neurobehavioural consequences of sleep disruption by tyre noise. The investigators will measure the sleep of healthy volunteers, and each morning the investigators will obtain blood samples for metabolomics analysis and administer a neurocognitive test battery. The investigators will compare effects on sleep, metabolomics and cognitive function between quiet nights and nights with road traffic noise.

Aim 2: Identify acoustical characteristics of tyre noise that are especially disturbing physiologically. The investigators will use different combinations of types of tyre noise in different noise exposure nights to determine differential effects on sleep and cardiovascular response.

This study will take place in the sound environment laboratory (SEL) at the University of Gothenburg Department of Occupational and Environmental Medicine (Arbets- och miljömedicin [AMM]). The SEL is a high fidelity research laboratory equipped to simulate a typical apartment, including three individually light-, sound- and vibration-isolated private bedrooms. Ceiling mounted speakers in each room allow the investigators to create a realistic acoustic environment by transmitting sound exposures from the control room to each bedroom individually. The investigators have shown previously that results from this lab with high ecological validity are comparable with results from the field.

There will be two study arms, each one affording the opportunity to investigate different acoustical characteristics of tyre noise and their physiological effects. Each of these study arms has a prospective within-subjects cross-over design. Participants (study 1 N=15; study 2 N=30; total N=45 across both arms) will each spend six consecutive nights in the SEL, with a sleep opportunity between 23:00-07:00. Daytime sleep will be prohibited, confirmed with measures of daytime activity via wrist actigraphy monitors worn continuously throughout the study. Three subjects will take part concurrently, in separate bedrooms. The first night is a habituation period to the study protocol and for familiarisation with the test procedures. Study nights 2-6 are the experimental nights and will be randomly assigned across participants using a Latin square design to avoid first-order carryover effects. Each subject will be exposed to each of the following:

One quiet night: No noise will be played, serving as a control night to assess individual baseline sleep, cardiometabolic profile, and cognitive performance;

Four traffic noise nights: Tyre noise from road traffic noise be played into the rooms to determine the effects of noise on sleep, cardiometabolic function and cognitive performance. These noise nights will be in a 2×2 factorial design so that the investigators can examine each combination of two specific noise characteristics.

Each night the investigators will record physiologic sleep with polysomnography (PSG) and cardiac activity with electrocardiography (ECG). Each study morning, subjects will provide a 4 ml blood sample, complete cognitive testing and answer questionnaires and will depart the SEL to follow their normal daytime routine. They will return to the SEL at 20:00 each evening to prepare for sleep measurements. Caffeine will be prohibited after 15:00 and alcohol will be prohibited at all times. Because extreme and/or variable dietary behaviour can affect the metabolome/lipoprotein profile, participants will be given guidance that they should eat a similar evening meal on each day of the laboratory study, confirmed with a food diary, The actual meal itself can be different for different study participants, because the study has a within-subjects design.

Sleep will be recorded with ambulatory polysomnography (PSG) and cardiac activity with electrocardiography (ECG) and finger pulse photoplethysmogram. Data are recorded offline onto the sleep recorder, and will be downloaded and checked every study morning to ensure data quality. In addition to traditional sleep analysis performed by the research group at the University of Gothenburg, raw PSG data will be used to calculate the Odds Ratio Project, a novel metric of sleep depth and stability.

Each study morning subjects will provide a 4 ml blood sample for plasma metabolomics analysis. To ensure reliable data, blood samples will be taken at the same time every day to mitigate circadian effects, before eating or drinking anything except water, and each sample will be handled in the same way i.e. centrifuged, aliquoted and stored in -80C freezers. Subjects will eat the same food each study evening to mitigate within-subject dietary effects on the blood metabolome.

Each morning, subjects will complete a computerised cognitive test battery taking approximately 20 minutes, that includes 10 tests across a range of cognitive domains (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance). Cognition data will be analysed to determine key measures of cognitive speed and accuracy, adjusting for practice effects and the difficulty of the stimulus set.

Subjects will complete a battery of one-time validated questionnaires to measure their general health (SF-36), chronotype, noise sensitivity, habitual sleep quality, environmental sensitivity, and annoyance and sleep disturbance by noise. Subjects will also answer a questionnaire each study evening and morning, involving questions on sleepiness (Karolinska Sleepiness Scale), sleep disturbance by noise, positive and negative affect (PANAS), and validated sleep and disturbance questions.

Participants will wear a wrist actigraphy monitor continuously throughout the study period, and also for the week before the study, to confirm habitual sleep-wake times and to measure physical activity levels.

• Study Type: Interventional
• Enrollment (Actual): 45
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Sweden
  • Västra Götaland
    • Gothenburg, Västra Götaland, Sweden, 42650
      • University of Gothenburg

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 30 years (Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. live in or around the city of Gothenburg area (Sweden)

Exclusion Criteria:

1. aged <18 or >30 years;
2. habitual sleep and wake timings more than ±1 hour different from the study sleep times (i.e. habitual sleep time should be 22:00-00:00 and habitual wake time should be 06:00-08:00);
3. BMI>25 kg/m2;
4. regular sleep medication use (prescribed or "over-the-counter");
5. poor hearing acuity (measured during screening via pure tone audiometry);
6. diagnosed with sleep disorders;
7. indications of sleep apnea on the STOP-BANG questionnaire;
8. shift work;
9. smoking, vaping, snus, or other nicotine use.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Basic Science
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Double

Number of Arms

9

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control; Single study night with no noise exposure, to determine normal baseline sleep
Experimental: Study 1: High level continuous flow tyre noise (A1); Single study night in first experimental study arm, with traffic noise to determine consequences of sleep disturbance by high level, continuous flow traffic noise. Noise will include mix of different acoustical characteristics of tyre noise throughout the night.	Radiation: Tyre noise - continuous flow; Tyre noise from continuous traffic, throughout the night; Radiation: High noise level; Tyre noise corresponding up to 65 dB LAEq,24h
Experimental: Study 1: Medium level continuous flow tyre noise (B1); Single study night in first experimental study arm, with traffic noise to determine consequences of sleep disturbance by medium level, continuous flow traffic noise. Noise will include mix of different acoustical characteristics of tyre noise throughout the night.	Radiation: Tyre noise - continuous flow; Tyre noise from continuous traffic, throughout the night; Radiation: Moderate noise level; Tyre noise corresponding up to 60 dB LAEq,24h
Experimental: Study 1: High level, discrete traffic tyre noise (A2); Single study night in first experimental study arm, with traffic noise events to determine consequences of sleep disturbance by high level traffic noise comprised of single, discrete traffic events. Noise will include mix of different acoustical characteristics of tyre noise throughout the night.	Radiation: High noise level; Tyre noise corresponding up to 65 dB LAEq,24h; Radiation: Tyre noise - discrete events; Tyre noise from few, discrete traffic events, occurring throughout the night
Experimental: Study 1: Medium level, discrete traffic tyre noise (B2); Single study night in first experimental study arm, with traffic noise events to determine consequences of sleep disturbance by moderate level traffic noise comprised of single, discrete traffic events. Noise will include mix of different acoustical characteristics of tyre noise throughout the night.	Radiation: Moderate noise level; Tyre noise corresponding up to 60 dB LAEq,24h; Radiation: Tyre noise - discrete events; Tyre noise from few, discrete traffic events, occurring throughout the night
Experimental: Study 2: Medium level composite wheel tyre noise (A1); Single study night in second experimental study arm, with traffic noise to determine consequences of sleep disturbance by medium level traffic noise comprised of composite wheel types.	Radiation: Moderate noise level; Tyre noise corresponding up to 60 dB LAEq,24h; Radiation: Composite tyres; Tyre noise from newly designed, airless composite tyres
Experimental: Study 2: Low level composite wheel tyre noise (B1); Single study night in second experimental study arm, with traffic noise to determine consequences of sleep disturbance by low level traffic noise comprised of composite wheel types.	Radiation: Composite tyres; Tyre noise from newly designed, airless composite tyres; Radiation: Low noise level; Tyre noise corresponding up to 55 dB LAEq,24h
Experimental: Study 2: Medium level air-filled tyre noise (A2); Single study night in second experimental study arm, with traffic noise to determine consequences of sleep disturbance by medium level traffic noise comprised of traditional air-filled wheel types.	Radiation: Moderate noise level; Tyre noise corresponding up to 60 dB LAEq,24h; Radiation: Air-filled tyres; Tyre noise from traditional, air-filled tyres
Experimental: Study 2: Low level air-filled tyre noise (B2); Single study night in second experimental study arm, with traffic noise to determine consequences of sleep disturbance by low level traffic noise comprised of traditional air-filled wheel types.	Radiation: Low noise level; Tyre noise corresponding up to 55 dB LAEq,24h; Radiation: Air-filled tyres; Tyre noise from traditional, air-filled tyres

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Baseline total sleep time during the Control night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline total sleep time during the A1 night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline total sleep time during the A2 night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline total sleep time during the B1 night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline total sleep time during the B2 night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total sleep time during exposure to nocturnal tyre noise combination A1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total sleep time during exposure to nocturnal tyre noise combination A2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total sleep time during exposure to nocturnal tyre noise combination B1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total sleep time during exposure to nocturnal tyre noise combination B2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of baseline N1 sleep during the Control night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of baseline N2 sleep during the Control night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of baseline N3 sleep during the Control night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of baseline rapid eye movement (REM) sleep during the Control night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N1 sleep during exposure to nocturnal tyre noise combination A1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N2 sleep during exposure to nocturnal tyre noise combination A1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N3 sleep during exposure to nocturnal tyre noise combination A1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of rapid eye movement (REM) sleep during exposure to nocturnal tyre noise combination A1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N1 sleep during exposure to nocturnal tyre noise combination A2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N2 sleep during exposure to nocturnal tyre noise combination A2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N3 sleep during exposure to nocturnal tyre noise combination A2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of rapid eye movement (REM) sleep during exposure to nocturnal tyre noise combination A2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N1 sleep during exposure to nocturnal tyre noise combination B1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N2 sleep during exposure to nocturnal tyre noise combination B1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N3 sleep during exposure to nocturnal tyre noise combination B1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of rapid eye movement (REM) sleep during exposure to nocturnal tyre noise combination B1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N1 sleep during exposure to nocturnal tyre noise combination B2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N2 sleep during exposure to nocturnal tyre noise combination B2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of N3 sleep during exposure to nocturnal tyre noise combination B2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Total amount of rapid eye movement (REM) sleep during exposure to nocturnal tyre noise combination B2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline wakefulness after sleep onset (WASO) during the Control night	Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Wakefulness after sleep onset (WASO) during exposure to nocturnal tyre noise combination A1	Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Wakefulness after sleep onset (WASO) during exposure to nocturnal tyre noise combination A2	Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Wakefulness after sleep onset (WASO) during exposure to nocturnal tyre noise combination B1	Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Wakefulness after sleep onset (WASO) during exposure to nocturnal tyre noise combination B2	Total number of minutes awake during the night after the first appearance of sleep of any stage. Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline number of awakenings during the Control night	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Number of awakenings during exposure to nocturnal tyre noise combination A1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Number of awakenings during exposure to nocturnal tyre noise combination A2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Number of awakenings during exposure to nocturnal tyre noise combination B1	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Number of awakenings during exposure to nocturnal tyre noise combination B2	Measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines	One night
Baseline sleep onset latency (SOL) during the Control night	Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep onset latency (SOL) during exposure to nocturnal tyre noise combination A1	Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep onset latency (SOL) during exposure to nocturnal tyre noise combination A2	Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep onset latency (SOL) during exposure to nocturnal tyre noise combination B1	Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep onset latency (SOL) during exposure to nocturnal tyre noise combination B2	Defined as the time from lights out to the first epoch of sleep measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Baseline sleep efficiency during the Control night	Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep efficiency during exposure to nocturnal tyre noise combination A1	Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep efficiency during exposure to nocturnal tyre noise combination A2	Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep efficiency during exposure to nocturnal tyre noise combination B1	Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Sleep efficiency during exposure to nocturnal tyre noise combination B2	Defined as the percentage of time in bed spent in a non-wake sleep stage, measured via polysomnography/EEG, scored according to American Academy of Sleep Medicine guidelines.	One night
Baseline sleep depth assessed using the odds ratio product (ORP) during the Control night	Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.	One night
Sleep depth assessed using the odds ratio product (ORP) during exposure to nocturnal tyre noise combination A1	Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.	One night
Sleep depth assessed using the odds ratio product (ORP) during exposure to nocturnal tyre noise combination A2	Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.	One night
Sleep depth assessed using the odds ratio product (ORP) during exposure to nocturnal tyre noise combination B1	Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.	One night
Sleep depth assessed using the odds ratio product (ORP) during exposure to nocturnal tyre noise combination B2	Average ORP over the full night, from 0 (never occurs during wake) to 2.5 (only occurs during wake). Derived via polysomnography/EEG measurements.	One night
Spontaneous maximal change of odds ratio product (ORP) during the Control night	Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over 120 sham noise events during the night.	One night
Maximal change of odds ratio product (ORP) during exposure to tyre noise events combination A1	Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over all 120 noise events during the night.	One night
Maximal change of odds ratio product (ORP) during exposure to tyre noise events combination A2	Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over all 120 noise events during the night.	One night
Maximal change of odds ratio product (ORP) during exposure to tyre noise events combination B1	Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over all 120 noise events during the night.	One night
Maximal change of odds ratio product (ORP) during exposure to tyre noise events combination B2	Primary measure of acute sleep disruption by noise, calculated as the difference between the ORP in the 30s prior to noise onset and the maximum ORP during traffic noise. Averaged over all 120 noise events during the night.	One night
Morning neurobehavioural speed in the morning immediately after the Control night	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Morning neurobehavioural speed in the morning immediately after the A1 night	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Morning neurobehavioural speed in the morning immediately after the A2 night	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Morning neurobehavioural speed in the morning immediately after the B1 night	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Morning neurobehavioural speed in the morning immediately after the B2 night	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Morning neurobehavioural accuracy in the morning after the control night	Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Morning neurobehavioural accuracy in the morning after exposure to nocturnal tyre noise combination A1	Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Morning neurobehavioural accuracy in the morning after exposure to nocturnal tyre noise combination A2	Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Morning neurobehavioural accuracy in the morning after exposure to nocturnal tyre noise combination B1	Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Morning neurobehavioural accuracy in the morning after exposure to nocturnal tyre noise combination B2	Average of one key accuracy indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Baseline evening neurobehavioural speed following the Control night	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Evening neurobehavioural speed after exposure to nocturnal tyre noise combination A1	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Evening neurobehavioural speed after exposure to nocturnal tyre noise combination A2	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Evening neurobehavioural speed after exposure to nocturnal tyre noise combination B1	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Evening neurobehavioural speed after exposure to nocturnal tyre noise combination B2	Average of one key speed indicator from each of 10 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, balloon analog risk, psychomotor vigilance)	One night
Baseline evening neurobehavioural accuracy following the Control night	Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance	One night
Evening neurobehavioural accuracy after exposure to nocturnal tyre noise combination A1	Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Evening neurobehavioural accuracy after exposure to nocturnal tyre noise combination A2	Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Evening neurobehavioural accuracy after exposure to nocturnal tyre noise combination B1	Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Evening neurobehavioural accuracy after exposure to nocturnal tyre noise combination B2	Average of one key speed indicator from each of 9 cognitive tests (motor praxis, visual object learning, fractal 2-back, abstract matching, line orientation, emotion recognition, matrix reasoning, digit symbol substitution, psychomotor vigilance)	One night
Event-related Cardiovascular activation in response to noise during Control night	Change in heart rate (ECG)	One night
Event-related Cardiovascular activation in response to noise during A1	Change in heart rate (ECG)	One night
Event-related Cardiovascular activation in response to noise during A2	Change in heart rate (ECG)	One night
Event-related Cardiovascular activation in response to noise during B1	Change in heart rate (ECG)	One night
Event-related Cardiovascular activation in response to noise during B2	Change in heart rate (ECG)	One night
Evening subjective sleepiness, assessed using the Karolinska Sleepiness Scale on the control night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Evening subjective sleepiness, assessed using the Karolinska Sleepiness Scale on the A1 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Evening subjective sleepiness, assessed using the Karolinska Sleepiness Scale on the A2 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Evening subjective sleepiness, assessed using the Karolinska Sleepiness Scale on the B1 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Evening subjective sleepiness, assessed using the Karolinska Sleepiness Scale on the B2 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Morning subjective sleepiness, assessed using the Karolinska Sleepiness Scale after the control night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Morning subjective sleepiness, assessed using the Karolinska Sleepiness Scale after the A1 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Morning subjective sleepiness, assessed using the Karolinska Sleepiness Scale after the A2 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Morning subjective sleepiness, assessed using the Karolinska Sleepiness Scale after the B1 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Morning subjective sleepiness, assessed using the Karolinska Sleepiness Scale after the B2 night	The scale is a 9-level verbal scale from 1 - "Extremely alert" (best outcome) to 9 - "Very sleepy. great effort to keep alert, fighting sleep" (worst outcome)	One night
Taurine concentration (mmol/L) immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Taurine concentration (mmol/L) in the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Taurine concentration (mmol/L) in the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Taurine concentration (mmol/L) in the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Taurine concentration (mmol/L) in the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Serotonin concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Serotonin concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Serotonin concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Serotonin concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Serotonin concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Tryptophan concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Tryptophan concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Tryptophan concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Tryptophan concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Tryptophan concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Isoleucine concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Isoleucine concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Isoleucine concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Isoleucine concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Isoleucine concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Leucine concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Leucine concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Leucine concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Leucine concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Leucine concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Valine concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Valine concentration (mmol/L)In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Valine concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Valine concentration (mmol/L)In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Valine concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Diacylglycerol (36:3) concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Diacylglycerol (36:3) concentration (mmol/L)In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Diacylglycerol (36:3) concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Diacylglycerol (36:3) concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Diacylglycerol (36:3) concentration (mmol/L)In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Lauroylcarnitine (C12:0) concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Lauroylcarnitine (C12:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Lauroylcarnitine (C12:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Lauroylcarnitine (C12:0) concentration (mmol/L)In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Lauroylcarnitine (C12:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Octanoylcarnitine (C8:0) concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Octanoylcarnitine (C8:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Octanoylcarnitine (C8:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Octanoylcarnitine (C8:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Octanoylcarnitine (C8:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Myristoylcarnitine (C14:0) concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Myristoylcarnitine (C14:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Myristoylcarnitine (C14:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Myristoylcarnitine (C14:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Myristoylcarnitine (C14:0) concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline 1-Methyl-4-pyridone-5-carboxamide (4-Pyr) concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
1-Methyl-4-pyridone-5-carboxamide (4-Pyr) concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
1-Methyl-4-pyridone-5-carboxamide (4-Pyr) concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
1-Methyl-4-pyridone-5-carboxamide (4-Pyr) concentration (mmol/L)In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
1-Methyl-4-pyridone-5-carboxamide (4-Pyr) concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Phenylalanine concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Phenylalanine concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Phenylalanine concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Phenylalanine concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Phenylalanine concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Acylcarnitine C18:1 concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C18:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C18:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C18:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C18:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Acylcarnitine C10:0 concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C10:0 concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C10:0 concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C10:0 concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Acylcarnitine C10:0 concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Phosphatidylcholine 32:1 concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 32:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 32:1 concentration (mmol/L)In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 32:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 32:1 concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Basline Phosphatidylcholine 38:2 concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:2 concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:2 concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:2 concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:2 concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night
Baseline Phosphatidylcholine 38:3 concentration (mmol/L) In the morning immediately after the Control night	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:3 concentration (mmol/L) In the morning immediately after the Tyre noise combination A1	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:3 concentration (mmol/L) In the morning immediately after the Tyre noise combination A2	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:3 concentration (mmol/L) In the morning immediately after the Tyre noise combination B1	Determined from GC-MS analysis of blood plasma	One night
Phosphatidylcholine 38:3 concentration (mmol/L) In the morning immediately after the Tyre noise combination B2	Determined from GC-MS analysis of blood plasma	One night

Collaborators and Investigators

• Sponsor: Göteborg University
• Collaborators: University of Manitoba; University of Pennsylvania; Swedish National Road and Transport Research Institute
• Investigators: Principal Investigator: Michael G Smith, PhD, Göteborg University

Study record dates

Study Major Dates

• Study Start (Actual): January 30, 2023
• Primary Completion (Actual): June 16, 2023
• Study Completion (Actual): December 15, 2023

Study Registration Dates

• First Submitted: September 23, 2022
• First Submitted That Met QC Criteria: November 3, 2022
• First Posted (Actual): November 10, 2022

Study Record Updates

• Last Update Posted (Actual): January 5, 2024
• Last Update Submitted That Met QC Criteria: January 3, 2024
• Last Verified: January 1, 2024

More Information

Terms related to this study

• Keywords: Metabolomics; Polysomnography; Neurobehavioural Performance
• Additional Relevant MeSH Terms: Mental Disorders; Nervous System Diseases; Sleep Wake Disorders; Dyssomnias; Parasomnias
• Other Study ID Numbers: 254066204

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No